Dentsply Sirona (NASDAQ:XRAY) Misses Q4 Sales Targets, Stock Drops
Dental products company Dentsply Sirona (NASDAQ:XRAY) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 10.6% year on year to $905 million. The company’s full-year revenue guidance of $3.55 billion at the midpoint came in 5% below analysts’ estimates. Its non-GAAP profit of $0.26 per share was 40.1% below analysts’ consensus estimates.